HOUSTON, July 25, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the company has identified a third site as well

ATLANTA, July 25, 2019 /PRNewswire/ -- The challenge of recruiting and retaining physicians to work in rural communities has reached a new level of urgency for health systems. While hospital administrators often think compensation is the top factor influencing a physician's decision to practice in a rural setting, a new survey conducted by

WASHINGTON, July 25, 2019 /PRNewswire/ -- A new report released today by the Sabin-Aspen Vaccine Science & Policy Group, a joint initiative of the Sabin Vaccine Institute and the Aspen Institute, calls for an urgent, coordinated effort to amplify and focus resources on the long-sought, but overdue achievement of a universal influenza vaccine (UIV). The re

CHARLOTTESVILLE, Va., and WATERLOO, Ontario, July 25, 2019 /PRNewswire/ -- Caretaker Medical, maker of the Wireless Caretaker® Finger-Cuff Patient Monitoring Platform for Continuous Non-Invasive Blood Pressure ("CNIBP") & Wireless Vital Signs, and Mespere LifeSciences, an innovator in non-invasive cardiac and cerebral hemodyn

CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Obsidian Therapeutics, a biotechnology company pioneering controllable cell and gene therapies, today announced executive management appointments that organizationally support the Company's long-term strategy. Specifically, the Company announced the appointment of Catherine Stehman-Breen, M.D.

BOSTON, July 25, 2019 /PRNewswire/ -- Intervention Insights announces the appointment of Chet Burrell as its Executive Chairman to support the continued growth of its distinct, precision diagnostic platform

NASDAQ: CORV   TSX: CORVNDA Seeks Approval for Brinavess for the Treatment of Recent Onset Atrial Fibrillation; PDUFA Date Set for December 24, 2019Company Also Reports Certain Preliminary Financial Results for Second Quarter 2019 VANCOUVER, July 25, 2019 /PRN

MISSISSAUGA, ON, July 25, 2019 /PRNewswire/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today commented on the issuance by the UK Competition and Markets Authori

BURLINGTON, ON, July 25, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) announced today t

REDWOOD CITY, Calif., July 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that U.S. District Judge Colm Connolly, in the District of Delaware, granted Nevro's motion fo